Intranasal Lidocaine for Primary Headache Management in Emergency Department; a Clinical Trial
Hassan Barzegari, Hassan Motamed, Behrad Ziapour, Majid Hajimohammadi, Mina Kadkhodazadeh, Hassan Barzegari, Hassan Motamed, Behrad Ziapour, Majid Hajimohammadi, Mina Kadkhodazadeh
Abstract
Introduction: Most of the headache cases only require pain management in emergency department (ED). The present study aimed to evaluate the efficacy of intranasal lidocaine in this regard.
Method: In this clinical trial, adult patients with primary headache were randomly treated with 7.5 mg intravenous (IV) chlorpromazine and 1 ml intranasal lidocaine 2% (treatment) or normal saline 0.9% (placebo), and were compared 5, 15, and 30 minutes later regarding success rate using SPSS 21.
Result: 100 patients were assigned to either treatment or placebo group. Number needed to treat of intranasal lidocaine at 5, 15, and 30 minutes were 4 (95% CI: 2.2 - 6.6), 3 (95% CI: 1.7 - 3.5), and 4 (95% CI: 2.3 - 15.9), respectively. These measures for absolute risk reduction were 30 (95% CI: 15.2 - 44.8), 44 (95% CI: 28.7 - 59.3), and 26 percent (95% CI: 6.3 - 44.3), respectively. Pain relapse occurred in 16% of treatment and 11% of control group within 1 hour of treatment (p = 0.402).
Conclusion: It seems that, intranasal lidocaine along with IV chlorpromazine could result in more successful and faster management of primary headaches in ED.
Keywords: Pain management; administration; intranasal; lidocaine; migraine disorders; tension-type Headache.
Figures
References
- Go S. Nontraumatic headaches in the Emergency Department: a systematic approach to diagnosis and controversies in two" big ticket" entities. Missouri medicine. 2008;106(2):156–61.
- Edvinsson L. Pathophysiology of primary headaches. Current pain and headache reports. 2001;5(1):71–8.
- Rapoport AM, Bigal ME, Tepper SJ, Sheftell FD. Intranasal medications for the treatment of migraine and cluster headache. CNS drugs. 2004;18(10):671–85.
- Van Vliet J, Bahra A, Martin V, Ramadan N, Aurora S, Mathew N, et al. Intranasal sumatriptan in cluster headache Randomized placebo-controlled double-blind study. Neurology. 2003;60(4):630–3.
- Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Archives of neurology. 2006;63(11):1537–42.
- Diamond S, Freitag F, Phillips S, Bernstein J, Saper J. Intranasal Civamide for the Acute Treatment of Migraine Headache. Cephalalgia. 2000;20(6):597–602.
- Costa A, Pucci E, Antonaci F, Sances G, Granella F, Broich G, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin‐induced attacks in cluster headache. Cephalalgia. 2000;20(2):85–91.
- Robbins L. Intranasal Lidocaine for Cluster Headache. Headache: The Journal of Head and Face Pain. 1995;35(2):83–4.
- Mohammadkarimi N, Jafari M, Mellat A, Kazemi E, Shirali A. Evaluation of efficacy of intra-nasal lidocaine for headache relief in patients refer to emergency department. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2014;19(4):331.
- Generali J, Cada DJ. Intranasal lidocaine: Migraine headaches. Hospital Pharmacy. 2001;36(2):192–223.
- Blanda M, Rench T, Gerson LW, Weigand JV. Intranasal lidocaine for the treatment of migraine headache: a randomized, controlled trial. Academic Emergency Medicine. 2001;8(4):337–42.
- Maizels M, Geiger AM. Intranasal lidocaine for migraine: a randomized trial and open‐label follow‐up. Headache: The Journal of Head and Face Pain. 1999;39(8):543–51.
- Djupesland PG, Messina JC, Mahmoud RA. Breath Powered Nasal Delivery: A New Route to Rapid Headache Relief. Headache: The Journal of Head and Face Pain. 2013;53:72–84.
Source: PubMed